Approximately 60% of Australian general practices now administer intravenous iron,¹ demonstrating significant progress in managing iron deficiency in primary care. This contrasts with countries like Canada, where most intravenous iron is administered in hospitals.^2,3

Newer intravenous iron formulations have demonstrated favourable safety and efficacy characteristics compared with earlier preparations. However, minor reactions are common, and with increased usage, it’s particularly important that clinicians know how to minimise risk and recognise and manage potential reactions.^4,5